|
|
Volumn 10, Issue 5, 2001, Pages 985-989
|
|
Neurotoxicity as a mechanism for neurodegenerative disorders: Basic and clinical aspects
|
|
Author keywords
Alzheimer's disease; Amyotrophic lateral sclerosis; Neurodegenrative diseases; Neuroprotection; Parkinson's disease
|
|
Indexed keywords
1,4 NAPHTHOQUINONE DERIVATIVE;
2,3,6 TRIMETHYL 1H NAPHTHOQUINONE;
ACETYLCHOLINESTERASE;
ADENOSINE RECEPTOR;
ALPHA TOCOPHEROL;
AMANTADINE;
AMYLOID BETA PROTEIN;
ANTIOXIDANT;
CAFFEINE;
CARBIDOPA;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINESTERASE INHIBITOR;
CLOZAPINE;
CYCLOOXYGENASE 2 INHIBITOR;
DONEPEZIL;
DOPAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ESTROGEN;
GALANTAMINE;
GLUTAMINE;
INDOMETACIN;
ISTRADEFYLLINE;
LEVODOPA;
LITHIUM;
NICOTINE;
RASAGILINE;
RIVASTIGMINE;
SELEGILINE;
TACRINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ALZHEIMER DISEASE;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
CELL ACTIVATION;
CHILE;
CHRONIC DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEGENERATIVE DISEASE;
DRUG FORMULATION;
GLIA CELL;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INFLAMMATION;
MENTAL DISEASE;
MOUSE;
NERVE DEGENERATION;
NEUROTOXICITY;
NONHUMAN;
OXIDATIVE STRESS;
PARKINSON DISEASE;
RAT;
UNITED STATES;
ALZHEIMER DISEASE;
AMYOTROPHIC LATERAL SCLEROSIS;
ANIMALS;
HUMANS;
LEVODOPA;
NERVE GROWTH FACTOR;
NEUROPROTECTIVE AGENTS;
NICOTINE;
PARKINSON DISEASE;
|
|
EID: 0035002133
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.10.5.985 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (10)
|
